Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.865 USD | +0.17% | -3.38% | +15.23% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 486M |
---|---|---|---|---|---|
Net income 2024 * | -89M | Net income 2025 * | -112M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.23
x | P/E ratio 2025 * |
-5.21
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.7% |
Latest transcript on Astria Therapeutics, Inc.
1 day | -0.23% | ||
1 week | -6.55% | ||
Current month | -6.55% | ||
1 month | -12.98% | ||
3 months | -38.33% | ||
6 months | +64.19% | ||
Current year | +15.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 08-06-25 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 11-03-31 |
Chief Tech/Sci/R&D Officer | 54 | 22-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 13-12-31 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 19-01-03 |
Director/Board Member | 75 | 16-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 8.81 | -0.45% | 40 860 |
24-06-07 | 8.85 | -0.23% | 219,789 |
24-06-06 | 8.87 | -3.38% | 289,464 |
24-06-05 | 9.18 | +2.74% | 442,286 |
24-06-04 | 8.935 | -2.46% | 431,984 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.23% | 486M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.73% | 22.78B | |
-10.72% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ATXS Stock